FDA National Drug Codes
Searching…
FDA National Drug Codes
Searching…
FDA National Drug Codes
Browse every product in the FDA NDC Directory below, or search by NDC, brand, generic, manufacturer or HCPCS code. Each product has its own page with package NDCs in 11-digit billing format.
4,454 products (finished products)
| Product | Strength | Form · route | Labeler | Application | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|---|
| Enoxaparin Sodium | Enoxaparin sodium 40 mg/.4mL | InjectionSubcutaneous | Fresenius Kabi USA, LLC | NDA authorized generic | 63323-535 | 63323-0535-87 | — |
| Enoxaparin Sodium | Enoxaparin sodium 150 mg/mL | InjectionSubcutaneous | Fresenius Kabi USA, LLC | NDA authorized generic | 63323-537 | 63323-0537-84 | — |
| Enoxaparin Sodium | Enoxaparin sodium 300 mg/3mL | InjectionIntravenous, Subcutaneous | Fresenius Kabi USA, LLC | NDA authorized generic | 63323-539 | 63323-0539-13 | — |
| Enoxaparin Sodium | Enoxaparin sodium 30 mg/.3mL | InjectionSubcutaneous | Fresenius Kabi USA, LLC |
| ANDA |
| 63323-559 |
| 63323-0559-93 |
| — |
| Enoxaparin Sodium | Enoxaparin sodium 40 mg/.4mL | InjectionSubcutaneous | Fresenius Kabi USA, LLC | ANDA | 63323-564 | 63323-0564-65 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 60 mg/.6mL | InjectionSubcutaneous | Fresenius Kabi USA, LLC | ANDA | 63323-566 | 63323-0566-65 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 80 mg/.8mL | InjectionSubcutaneous | Fresenius Kabi USA, LLC | ANDA | 63323-584 | 63323-0584-99 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | Fresenius Kabi USA, LLC | ANDA | 63323-586 | 63323-0586-96 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 150 mg/mL | InjectionSubcutaneous | Fresenius Kabi USA, LLC | ANDA | 63323-589 | 63323-0589-94 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | Fresenius Kabi USA, LLC | NDA authorized generic | 63323-605 | 63323-0605-94 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 60 mg/.6mL | InjectionSubcutaneous | Fresenius Kabi USA, LLC | NDA authorized generic | 63323-607 | 63323-0607-98 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 120 mg/.8mL | InjectionSubcutaneous | Fresenius Kabi USA, LLC | NDA authorized generic | 63323-609 | 63323-0609-90 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 120 mg/.8mL | InjectionSubcutaneous | Fresenius Kabi USA, LLC | ANDA | 63323-655 | 63323-0655-99 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | BluePoint Laboratories | ANDA | 68001-457 | 68001-0457-42 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | BluePoint Laboratories | ANDA | 68001-458 | 68001-0458-42 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | BluePoint Laboratories | ANDA | 68001-459 | 68001-0459-42 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | BluePoint Laboratories | ANDA | 68001-460 | 68001-0460-42 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | BluePoint Laboratories | ANDA | 68001-461 | 68001-0461-42 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 150 mg/mL | InjectionSubcutaneous | BluePoint Laboratories | ANDA | 68001-462 | 68001-0462-42 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 150 mg/mL | InjectionSubcutaneous | BluePoint Laboratories | ANDA | 68001-463 | 68001-0463-42 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 300 mg/3mL | InjectionIntravenous, Subcutaneous | BluePoint Laboratories | ANDA | 68001-464 | 68001-0464-41 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | BluePoint Laboratories | ANDA | 68001-633 | 68001-0633-42 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | BluePoint Laboratories | ANDA | 68001-634 | 68001-0634-42 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | BluePoint Laboratories | ANDA | 68001-635 | 68001-0635-42 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | BluePoint Laboratories | ANDA | 68001-636 | 68001-0636-42 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | BluePoint Laboratories | ANDA | 68001-637 | 68001-0637-42 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 150 mg/mL | InjectionSubcutaneous | BluePoint Laboratories | ANDA | 68001-638 | 68001-0638-42 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 150 mg/mL | InjectionSubcutaneous | BluePoint Laboratories | ANDA | 68001-639 | 68001-0639-42 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 300 mg/3mL | InjectionIntravenous, Subcutaneous | BluePoint Laboratories | ANDA | 68001-641 | 68001-0641-41 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 30 mg/.3mL | InjectionSubcutaneous | Gland Pharma Limited | ANDA | 68083-634 | 68083-0634-10 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 40 mg/.4mL | InjectionSubcutaneous | Gland Pharma Limited | ANDA | 68083-635 | 68083-0635-10 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 60 mg/.6mL | InjectionSubcutaneous | Gland Pharma Limited | ANDA | 68083-636 | 68083-0636-10 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 80 mg/.8mL | InjectionSubcutaneous | Gland Pharma Limited | ANDA | 68083-637 | 68083-0637-10 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | Gland Pharma Limited | ANDA | 68083-638 | 68083-0638-10 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 120 mg/.8mL | InjectionSubcutaneous | Gland Pharma Limited | ANDA | 68083-639 | 68083-0639-10 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 150 mg/mL | InjectionSubcutaneous | Gland Pharma Limited | ANDA | 68083-640 | 68083-0640-10 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 30 mg/.3mL | Injection, SolutionIntravenous, Subcutaneous | Zydus Pharmaceuticals USA Inc. | ANDA | 70710-1757 | 70710-1757-06 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 40 mg/.4mL | Injection, SolutionIntravenous, Subcutaneous | Zydus Pharmaceuticals USA Inc. | ANDA | 70710-1758 | 70710-1758-06 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 60 mg/.6mL | Injection, SolutionIntravenous, Subcutaneous | Zydus Pharmaceuticals USA Inc. | ANDA | 70710-1759 | 70710-1759-06 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 80 mg/.8mL | Injection, SolutionIntravenous, Subcutaneous | Zydus Pharmaceuticals USA Inc. | ANDA | 70710-1760 | 70710-1760-06 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | Injection, SolutionIntravenous, Subcutaneous | Zydus Pharmaceuticals USA Inc. | ANDA | 70710-1761 | 70710-1761-06 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 120 mg/.8mL | Injection, SolutionIntravenous, Subcutaneous | Zydus Pharmaceuticals USA Inc. | ANDA | 70710-1762 | 70710-1762-06 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 150 mg/mL | Injection, SolutionIntravenous, Subcutaneous | Zydus Pharmaceuticals USA Inc. | ANDA | 70710-1763 | 70710-1763-06 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 300 mg/3mL | InjectionIntravenous, Subcutaneous | Meitheal Pharmaceuticals Inc. | ANDA | 71288-426 | 71288-0426-03 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | Meitheal Pharmaceuticals Inc. | ANDA | 71288-432 | 71288-0432-81 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | Meitheal Pharmaceuticals Inc. | ANDA | 71288-433 | 71288-0433-83 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | Meitheal Pharmaceuticals Inc. | ANDA | 71288-434 | 71288-0434-85 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | Meitheal Pharmaceuticals Inc. | ANDA | 71288-435 | 71288-0435-87 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | Meitheal Pharmaceuticals Inc. | ANDA | 71288-436 | 71288-0436-89 | — |
|---|
| Enoxaparin Sodium | Enoxaparin sodium 150 mg/mL | InjectionSubcutaneous | Meitheal Pharmaceuticals Inc. | ANDA | 71288-437 | 71288-0437-92 | — |
|---|